ICMR to examine effectiveness of AstraZeneca's SII-produced Covishield and Bharat Biotech's Covaxin
India | May 26, 2021, 09:49 PM ISTAround 4K people above the age of 45 yrs who have taken either one or both doses of any of these two vaccines will be reviewed, according to Dr Tarun Bhatnagar, senior scientist at ICMR's NIE in Chennai.